Approximately 30−60% of cirrhotic patients exhibit metabolic impairment of blood glucose (hepatogenic diabetes) that reflects insulin resistance in the muscle, fat, and liver, as well as increasing secretion of insulin (hyperinsulinemia) [25]. This evidence concerns the gene INS and hyperinsulinism.